SG10201602555WA - Pharmaceutical Compositions Comprising Of Arsenous Acid, Its Sodium Salt And Its Derivatives Intended For The Treatment Of Urogenital Cancer And Its Metastasis - Google Patents
Pharmaceutical Compositions Comprising Of Arsenous Acid, Its Sodium Salt And Its Derivatives Intended For The Treatment Of Urogenital Cancer And Its MetastasisInfo
- Publication number
- SG10201602555WA SG10201602555WA SG10201602555WA SG10201602555WA SG10201602555WA SG 10201602555W A SG10201602555W A SG 10201602555WA SG 10201602555W A SG10201602555W A SG 10201602555WA SG 10201602555W A SG10201602555W A SG 10201602555WA SG 10201602555W A SG10201602555W A SG 10201602555WA
- Authority
- SG
- Singapore
- Prior art keywords
- metastasis
- treatment
- pharmaceutical compositions
- sodium salt
- arsenous acid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/36—Arsenic; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Production Of Liquid Hydrocarbon Mixture For Refining Petroleum (AREA)
- Luminescent Compositions (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Otolaryngology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05076071A EP1721615A1 (en) | 2005-05-09 | 2005-05-09 | Pharmaceutical compositions comprising sodium or potassium arsenite for the treatment of urogenital cancer and its metastasis |
Publications (1)
Publication Number | Publication Date |
---|---|
SG10201602555WA true SG10201602555WA (en) | 2016-05-30 |
Family
ID=35197739
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201602555WA SG10201602555WA (en) | 2005-05-09 | 2006-05-09 | Pharmaceutical Compositions Comprising Of Arsenous Acid, Its Sodium Salt And Its Derivatives Intended For The Treatment Of Urogenital Cancer And Its Metastasis |
SG2011075330A SG175633A1 (en) | 2005-05-09 | 2006-05-09 | Pharmaceutical compositions comprising of arsenous acid, its sodium salt and its derivatives intended for the treatment of urogenital cancer and its metastasis |
SG10201405278SA SG10201405278SA (en) | 2005-05-09 | 2006-05-09 | Pharmaceutical compositions comprising of arsenous acid, its sodium salt and its derivatives intended for the treatment of urogenital cancer and its metastasis |
SG2012003091A SG177983A1 (en) | 2005-05-09 | 2006-05-09 | Pharmaceutical compositions comprising of arsenous acid, its sodium salt and its derivatives intended for the treatment of urogenital cancer and its metastasis |
SG10202100785PA SG10202100785PA (en) | 2005-05-09 | 2006-05-09 | Pharmaceutical Compositions Comprising Of Arsenous Acid, Its Sodium Salt And Its Derivatives Intended For The Treatment Of Urogenital Cancer And Its Metastasis |
Family Applications After (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG2011075330A SG175633A1 (en) | 2005-05-09 | 2006-05-09 | Pharmaceutical compositions comprising of arsenous acid, its sodium salt and its derivatives intended for the treatment of urogenital cancer and its metastasis |
SG10201405278SA SG10201405278SA (en) | 2005-05-09 | 2006-05-09 | Pharmaceutical compositions comprising of arsenous acid, its sodium salt and its derivatives intended for the treatment of urogenital cancer and its metastasis |
SG2012003091A SG177983A1 (en) | 2005-05-09 | 2006-05-09 | Pharmaceutical compositions comprising of arsenous acid, its sodium salt and its derivatives intended for the treatment of urogenital cancer and its metastasis |
SG10202100785PA SG10202100785PA (en) | 2005-05-09 | 2006-05-09 | Pharmaceutical Compositions Comprising Of Arsenous Acid, Its Sodium Salt And Its Derivatives Intended For The Treatment Of Urogenital Cancer And Its Metastasis |
Country Status (24)
Country | Link |
---|---|
US (2) | US20090011047A1 (en) |
EP (5) | EP1721615A1 (en) |
JP (1) | JP5026408B2 (en) |
KR (3) | KR101413731B1 (en) |
CN (2) | CN104758312A (en) |
AR (1) | AR054448A1 (en) |
AU (1) | AU2006244767B2 (en) |
BR (1) | BRPI0608716A2 (en) |
CA (3) | CA2926846C (en) |
CY (2) | CY1113475T1 (en) |
DK (2) | DK1885380T3 (en) |
ES (2) | ES2394264T3 (en) |
HK (1) | HK1109736A1 (en) |
HU (1) | HUE046029T2 (en) |
IL (3) | IL187220A (en) |
LT (1) | LT3067068T (en) |
PL (2) | PL1885380T3 (en) |
PT (1) | PT1885380E (en) |
RU (1) | RU2401662C2 (en) |
SG (5) | SG10201602555WA (en) |
SI (2) | SI3067068T1 (en) |
TW (5) | TWI539957B (en) |
WO (1) | WO2006121280A1 (en) |
ZA (1) | ZA200710559B (en) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1721615A1 (en) | 2005-05-09 | 2006-11-15 | Komipharm International Co., Ltd. | Pharmaceutical compositions comprising sodium or potassium arsenite for the treatment of urogenital cancer and its metastasis |
US8945505B2 (en) * | 2007-02-02 | 2015-02-03 | Panaphix, Inc. | Use of arsenic compounds for treatment of pain and inflammation |
US20090246291A1 (en) | 2008-03-27 | 2009-10-01 | Angelika Burger | Method and compositions for treatment of cancer |
US20120045520A1 (en) * | 2008-08-21 | 2012-02-23 | Sang Bong Lee | Pharmaceutical composition comprising arsenite for the treatment of malignancy |
MX2012002855A (en) * | 2009-09-10 | 2012-07-20 | Kominox Inc | Cancer stem cell-targeted and drug resistant cancer therapy. |
MX2012002922A (en) * | 2009-09-18 | 2012-09-07 | Kominox Inc | Methods for treating brain tumors. |
EP2524226A1 (en) * | 2010-01-13 | 2012-11-21 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Promyelocytic leukemia protein as a redox sensor |
RU2602937C2 (en) * | 2011-01-11 | 2016-11-20 | Универзитет Базель | Combination of sirosingopin and mitochondrial inhibitors for treatment of cancer and for immunosuppression |
WO2012131487A2 (en) * | 2011-03-30 | 2012-10-04 | Kominox, Inc. | Compositions and methods for the treatment of cancer |
KR101309844B1 (en) * | 2013-03-15 | 2013-09-23 | 박상채 | Herbal medicine for enhancing anticancer activity and manufacturing method thereof |
RU2618405C1 (en) * | 2015-12-31 | 2017-05-03 | Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения Российской Федерации | Method for adjuvant chemotherapy duration determination in case of locally advanced colorectal cancer with metastases in regional lymph nodes after radical surgery |
US10806768B2 (en) * | 2016-05-26 | 2020-10-20 | Stephen N. Pitcher | Composition for promoting metallothionein production |
KR102487884B1 (en) | 2016-12-01 | 2023-01-11 | 유파마 피티와이 엘티디 | arsenic composition |
EA202092186A1 (en) * | 2018-03-22 | 2020-12-16 | Комифарм Интернэшнл Австралия Пти Лтд | PHARMACEUTICAL COMPOSITION CONTAINING METAARSENIT AND METHOD OF MANUFACTURING |
WO2019234112A1 (en) * | 2018-06-05 | 2019-12-12 | Katholieke Universiteit Leuven | Combination treatment of arsenic oxide and antiandrogens |
JP2023513795A (en) * | 2020-02-16 | 2023-04-03 | コミファーム インターナショナル オーストラリア ピーティーワイ リミテッド | Methods of treatment using meta arsenite |
KR20220020635A (en) * | 2020-08-12 | 2022-02-21 | 이상봉 | External preparation composition for promoting hair growth or preventing hair loss |
KR20220020637A (en) * | 2020-08-12 | 2022-02-21 | 이상봉 | Oral administration pharmaceutical composition for prevention of hair loss and improvement of hair growth comprising salt of meta-arsenite |
KR20220020633A (en) * | 2020-08-12 | 2022-02-21 | 이상봉 | Injectable composition for promoting hair growth or preventing hair loss |
CN112336746A (en) * | 2020-10-23 | 2021-02-09 | 内蒙古科技大学包头医学院 | Perfusion chemotherapeutic medicine for bladder cancer and application thereof |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4166452A (en) | 1976-05-03 | 1979-09-04 | Generales Constantine D J Jr | Apparatus for testing human responses to stimuli |
US4256108A (en) | 1977-04-07 | 1981-03-17 | Alza Corporation | Microporous-semipermeable laminated osmotic system |
FR2431686A1 (en) | 1978-07-20 | 1980-02-15 | Nestle Sa Soc Ass Tech Prod | DOSING AND BALANCING MECHANISM AND FILLING MACHINE COMPRISING SUCH A MECHANISM |
US4265874A (en) | 1980-04-25 | 1981-05-05 | Alza Corporation | Method of delivering drug with aid of effervescent activity generated in environment of use |
KR930001917A (en) * | 1991-07-26 | 1993-02-22 | 김두석 | Method of manufacturing malignant tumor treatment |
EP0804928B1 (en) * | 1994-02-18 | 2004-10-20 | Tamara Vasilievna Vorobieva | Agent having an immunomodulating effect and reducing disturbed functioning of the tissue cell propagation regulating system |
PT2018858E (en) * | 1997-10-15 | 2011-03-24 | Polarx Biopharmaceuticals Inc | Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic trioxide |
BR9814857A (en) | 1997-11-10 | 2001-12-26 | Sloan Kettering Inst Cancer | Processes for treating leukemia, solid cancer, leukemia, lymphoma or solid tumors in a human, and for making a sterile pharmaceutical composition, and the respective sterile pharmaceutical composition |
CN1233476A (en) * | 1998-04-24 | 1999-11-03 | 陆道培 | Medicine for treating acute leukemia, and method for preparing same |
KR20020083678A (en) * | 2001-04-28 | 2002-11-04 | 주식회사 한국미생물연구소 | Anticancer drug composition containing arsenic acid sodium salt, sodium meta arsenite or their mixture |
TW200408407A (en) | 2001-11-30 | 2004-06-01 | Dana Farber Cancer Inst Inc | Methods and compositions for modulating the immune system and uses thereof |
DK2042182T3 (en) * | 2002-04-10 | 2013-08-26 | Komipharm Int Co Ltd | Pharmaceutical composition comprising arsenic for the treatment of malignancy. |
KR100632250B1 (en) * | 2004-02-16 | 2006-10-11 | 정태호 | Anticancer agent containing arsenic compound as an active ingredient |
US20060104292A1 (en) | 2004-11-15 | 2006-05-18 | Gupta Vivek G | System and methods for supporting multiple communications interfaces with single client interface |
EP1721615A1 (en) | 2005-05-09 | 2006-11-15 | Komipharm International Co., Ltd. | Pharmaceutical compositions comprising sodium or potassium arsenite for the treatment of urogenital cancer and its metastasis |
US8945505B2 (en) | 2007-02-02 | 2015-02-03 | Panaphix, Inc. | Use of arsenic compounds for treatment of pain and inflammation |
US20090246291A1 (en) | 2008-03-27 | 2009-10-01 | Angelika Burger | Method and compositions for treatment of cancer |
MX2012002855A (en) | 2009-09-10 | 2012-07-20 | Kominox Inc | Cancer stem cell-targeted and drug resistant cancer therapy. |
-
2005
- 2005-05-09 EP EP05076071A patent/EP1721615A1/en not_active Withdrawn
-
2006
- 2006-05-09 US US11/631,962 patent/US20090011047A1/en not_active Abandoned
- 2006-05-09 LT LT16162414T patent/LT3067068T/en unknown
- 2006-05-09 ES ES06732912T patent/ES2394264T3/en active Active
- 2006-05-09 KR KR1020077028751A patent/KR101413731B1/en active IP Right Grant
- 2006-05-09 CN CN201510064962.8A patent/CN104758312A/en active Pending
- 2006-05-09 PL PL06732912T patent/PL1885380T3/en unknown
- 2006-05-09 PL PL16162414T patent/PL3067068T3/en unknown
- 2006-05-09 DK DK06732912.8T patent/DK1885380T3/en active
- 2006-05-09 SG SG10201602555WA patent/SG10201602555WA/en unknown
- 2006-05-09 WO PCT/KR2006/001731 patent/WO2006121280A1/en active Application Filing
- 2006-05-09 SI SI200632358T patent/SI3067068T1/en unknown
- 2006-05-09 TW TW101132058A patent/TWI539957B/en active
- 2006-05-09 SG SG2011075330A patent/SG175633A1/en unknown
- 2006-05-09 AR ARP060101851A patent/AR054448A1/en unknown
- 2006-05-09 AU AU2006244767A patent/AU2006244767B2/en active Active
- 2006-05-09 TW TW095116432A patent/TWI386214B/en active
- 2006-05-09 SG SG10201405278SA patent/SG10201405278SA/en unknown
- 2006-05-09 SI SI200631444T patent/SI1885380T1/en unknown
- 2006-05-09 JP JP2008511051A patent/JP5026408B2/en active Active
- 2006-05-09 RU RU2007145489/14A patent/RU2401662C2/en active
- 2006-05-09 TW TW103132530A patent/TWI522105B/en active
- 2006-05-09 ES ES16162414T patent/ES2754372T3/en active Active
- 2006-05-09 KR KR1020167007395A patent/KR20160035101A/en not_active Application Discontinuation
- 2006-05-09 DK DK16162414T patent/DK3067068T3/en active
- 2006-05-09 EP EP06732912A patent/EP1885380B1/en active Active
- 2006-05-09 SG SG2012003091A patent/SG177983A1/en unknown
- 2006-05-09 HU HUE16162414A patent/HUE046029T2/en unknown
- 2006-05-09 CA CA2926846A patent/CA2926846C/en active Active
- 2006-05-09 SG SG10202100785PA patent/SG10202100785PA/en unknown
- 2006-05-09 EP EP14166070.4A patent/EP2762145A1/en not_active Ceased
- 2006-05-09 TW TW105102103A patent/TW201615200A/en unknown
- 2006-05-09 PT PT06732912T patent/PT1885380E/en unknown
- 2006-05-09 CA CA2608035A patent/CA2608035C/en active Active
- 2006-05-09 TW TW104124162A patent/TWI574692B/en active
- 2006-05-09 BR BRPI0608716-7A patent/BRPI0608716A2/en not_active Application Discontinuation
- 2006-05-09 CA CA2840609A patent/CA2840609C/en active Active
- 2006-05-09 KR KR1020157017831A patent/KR20150085122A/en not_active Application Discontinuation
- 2006-05-09 CN CNA2006800250320A patent/CN101277707A/en active Pending
- 2006-05-09 EP EP16162414.3A patent/EP3067068B1/en active Active
- 2006-05-09 EP EP11165670.8A patent/EP2361628A1/en not_active Ceased
-
2007
- 2007-11-07 IL IL187220A patent/IL187220A/en active IP Right Grant
- 2007-12-04 ZA ZA200710559A patent/ZA200710559B/en unknown
-
2008
- 2008-03-17 HK HK08103067.4A patent/HK1109736A1/en unknown
-
2012
- 2012-10-10 CY CY20121100940T patent/CY1113475T1/en unknown
-
2013
- 2013-12-17 IL IL229975A patent/IL229975A/en active IP Right Grant
-
2016
- 2016-03-22 IL IL244728A patent/IL244728A0/en unknown
- 2016-03-22 US US15/077,373 patent/US11464859B2/en active Active
-
2019
- 2019-11-06 CY CY20191101162T patent/CY1122522T1/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL229975A0 (en) | Pharmaceutical compositions comprising of arsenous acid, its sodium salt and its derivatives intended for the treatment of urogenital cancer and its metastasis | |
ZA200707638B (en) | Pharmaceutical composition comprising an omega-carboxyaryl substituted diphenyl urea for the treatment of cancer | |
IL192763A (en) | Pyrimidine derivatives, compositions comprising them and use thereof for the manufacture of medicaments for the treatment of cancer | |
IL190137A0 (en) | Crystals of laquinimod sodium, and process for the manufacture thereof | |
IL199151A (en) | Pyrimidine derivatives, pharmaceutical compositions comprising them, their use in the treatment of cancer and kits comprising them | |
EP1730163A4 (en) | Pharmaceuticals salts of 3-o-(3,3-dimethylsuccinyl) betulinic acid | |
IL189737A0 (en) | Pyrazine derivatives, their preparation and pharmaceutical compositions containing them | |
ZA200805163B (en) | Isoquinoline aminopyrazole derivatives, their manufacture and use as pharmaceutical agents for the treatment of cancer | |
IL195731A0 (en) | Pyrimidine derivatives useful in the treatment of cancer | |
IL197941A0 (en) | Use of anilinopyrimidine derivatives for the preparation of pharmaceutical compositions for treating non-alcoholic liver diseases | |
SI1860098T1 (en) | Novel anthranilic acid derivative or salt thereof | |
TWI367761B (en) | Pharmaceutical composition containing hardly water soluble pharmaceutical substance | |
PL1863495T3 (en) | Calcium and sodium salt of myo-inositol 1,6:2,3:4,5 tripyrophosphate for treating cancer | |
HUP0600293A3 (en) | Zinc salt of rosuvastatine, process for its preparation and pharmaceutical compositions containing it | |
SI1707564T1 (en) | Indanyl-piperazine derivatives, process for their preparation and pharmaceutical compositions containing them | |
IL187655A0 (en) | Anthranilic acid derivatives | |
EP1904088A4 (en) | Compositions and methods for the treatment of cancer | |
IL186022A0 (en) | Dermatological compositions and salts for the treatment of dermatological diseases | |
IL194094A0 (en) | Stable pharmacuetical compositions of 2-aza-bicyclol[3.3.0]-octane-3-carboxylic acid derivatives | |
IL198848A0 (en) | Sodium salt of disaccharide compound, method for producing the same, and use of the same | |
IL190230A0 (en) | Derivatives of 2-aminthiazoles and 2-aminooxazoles, processes for their preparation and their use as pharmaceuticals | |
EP1948162A4 (en) | Pharmaceutical compositions containing erythrine mulungu derivatives and processes for their production | |
IL187419A0 (en) | Heteroarylethenyl derivatives, their manufacture and use as pharmaceutical agents | |
ZA200706710B (en) | 6-Phenylhex-5-enoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions them, and therapeutic uses thereof | |
ZA200810524B (en) | Pyrimidine derivatives useful in the treatment of cancer |